NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1.

[1]  T. Billiar,et al.  Role of Heme Oxygenase 1 in TNF/TNF Receptor–Mediated Apoptosis After Hepatic Ischemia/Reperfusion in Rats , 2013, Shock.

[2]  M. Haneklaus,et al.  Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments. , 2013, Current opinion in immunology.

[3]  V. Dixit.  Nlrp3 Inflammasome Activation in Type 2 Diabetes: Is It Clinically Relevant? , 2012, Diabetes.

[4]  R. Weiskirchen,et al.  Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease , 2012, Journal of Inflammation.

[5]  A. Rubartelli.  Redox control of NLRP3 inflammasome activation in health and disease , 2012, Journal of leukocyte biology.

[6]  B. Ryffel,et al.  ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation , 2012, Cell Death and Disease.

[7]  E. Alnemri,et al.  Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation* , 2012, The Journal of Biological Chemistry.

[8]  F. Urano,et al.  Thioredoxin-interacting protein mediates ER stress-induced β cell death through initiation of the inflammasome. , 2012, Cell metabolism.

[9]  K. Kim,et al.  Isorhamnetin-3-O-galactoside Protects against CCl4-Induced Hepatic Injury in Mice , 2012, Biomolecules & therapeutics.

[10]  C. Artlett.  The Role of the NLRP3 Inflammasome in Fibrosis , 2012, The open rheumatology journal.

[11]  M. Alcaraz,et al.  Heme oxygenase-1 mediates protective effects on inflammatory, catabolic and senescence responses induced by interleukin-1β in osteoarthritic osteoblasts. , 2012, Biochemical pharmacology.

[12]  Richard A. Flavell,et al.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.

[13]  M. Netea,et al.  Interplay between redox status and inflammasome activation. , 2011, Trends in immunology.

[14]  G. Szabo,et al.  Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver. , 2011, World journal of gastroenterology.

[15]  P. Zhu,et al.  Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice. , 2011, Human gene therapy.

[16]  T. Kang,et al.  Polyacetylene Compound from Cirsium japonicum var. ussuriense inhibits the LPS-Induced Inflammatory Reaction via Suppression of NF-κB Activity in RAW 264.7 Cells , 2011 .

[17]  S. Ryter,et al.  Heme oxygenase-1/carbon monoxide: novel therapeutic strategies in critical care medicine. , 2010, Current drug targets.

[18]  Sun-Mee Lee,et al.  Protective role of heme oxygenase-1 against liver damage caused by hepatic ischemia and reperfusion in rats. , 2010, Antioxidants & redox signaling.

[19]  A. Martini,et al.  Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1β secretion , 2010, Proceedings of the National Academy of Sciences.

[20]  Dirk E. Smith,et al.  The IL-1 family: regulators of immunity , 2010, Nature Reviews Immunology.

[21]  J. Tschopp,et al.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.

[22]  H. Farghali,et al.  Resveratrol attenuates lipopolysaccharide-induced hepatitis in D-galactosamine sensitized rats: role of nitric oxide synthase 2 and heme oxygenase-1. , 2009, Nitric oxide : biology and chemistry.

[23]  F. Sutterwala,et al.  The NLRP3 inflammasome: a sensor of immune danger signals. , 2009, Seminars in immunology.

[24]  T. Tsujimoto,et al.  Therapeutic approach to regulate innate immune response by Toll‐like receptor 4 antagonist E5564 in rats with D‐galactosamine‐induced acute severe liver injury , 2009, Journal of gastroenterology and hepatology.

[25]  G. Kollias,et al.  Myeloid heme oxygenase–1 regulates innate immunity and autoimmunity by modulating IFN-β production , 2009, The Journal of experimental medicine.

[26]  J. Ting,et al.  The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. , 2009, Immunity.

[27]  F. Sutterwala,et al.  Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. , 2009, The Journal of clinical investigation.

[28]  J. Wan,et al.  Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1. , 2008, European journal of pharmacology.

[29]  J. Tschopp,et al.  Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica , 2008, Science.

[30]  J. Chung,et al.  Diverse functions of VDUP1 in cell proliferation, differentiation, and diseases. , 2007, Cellular & molecular immunology.

[31]  Hao Wu,et al.  Upregulation of heme oxygenase-1 with hemin prevents D-galactosamine and lipopolysaccharide-induced acute hepatic injury in rats. , 2007, Toxicology.

[32]  S. Ryter,et al.  Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts , 2006, The Journal of experimental medicine.

[33]  Mehmet Toner,et al.  A Fulminant Hepatic Failure Model in the Rat , 2001, Digestive Diseases and Sciences.

[34]  G. Tiegs,et al.  Cytokine expression in three mouse models of experimental hepatitis. , 2002, Cytokine.

[35]  T. Minamino,et al.  Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  V. Ben-Shaul,et al.  Lipopolysaccharide-induced oxidative stress in the liver: comparison between rat and rabbit. , 1999, Shock.

[37]  P. Clavien,et al.  Interleukin‐6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent , 1997, Hepatology.

[38]  M. Maines.  Carbon monoxide and nitric oxide homology: differential modulation of heme oxygenases in brain and detection of protein and activity. , 1996, Methods in enzymology.

[39]  K. Nouri-Aria,et al.  ENHANCED TUMOUR NECROSIS FACTOR AND INTERLEUKIN-1 IN FULMINANT HEPATIC FAILURE , 1988, The Lancet.

[40]  S. Aust,et al.  Microsomal lipid peroxidation. , 1978, Methods in enzymology.

[41]  H. B. Burch,et al.  Enzymatic assay for glutathione. , 1976, Analytical biochemistry.

[42]  McFARLAN Am,et al.  Poliomyelitis and tonsillectomy. , 1948 .